BASi (Bioanalytical Systems, Inc.) (NASDAQ: BASI) announced today that it is collaborating with Pinnacle Technology Inc. in proof-of-concept studies combining BASi's Culex® NxT automated blood sampling system with Pinnacle's glucose sensor to create an innovative new option for high quality data collection for diabetes and other ... read more

CryoXtract Instruments, LLC, a leader in developing unique laboratory and scientific instruments for preserving and optimizing frozen biological samples, announced the introduction of its CXT 350T Frozen Tissue Aliquotter. The CXT 350T represents the industry’s first system that allows for targeted, repeated and safe access to ... read more

A new molecular test from bioTheranostics—the Prostate Cancer Index—is a strong predictor of prostate cancer recurrence and may improve upon the current standard of care for assessing risk of recurrence and metastasis in patients with prostate cancer, according to a study published online in the Proceedings ... read more

How do researchers know whether new molecules will have a positive or negative effect? How much does the technique for moving a liquid affect the results? What about testing compounds for their environmental or health impacts: Is one liquid handling process better than another when it ... read more

InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that the Company has been named one of the Best Places to Work in Massachusetts by the The Boston Business Journal in ... read more

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced results from two studies that are featured in oral presentations this week at IMPAKT Breast Cancer Conference. The studies demonstrated that the Prosigna™ Breast Cancer Prognostic ... read more

Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (“HA”) technology, today reported financial results for the quarter ended March 31, 2013. Management ... read more

Anacor Pharmaceuticals (NASDAQ:ANAC) announced today the completion of its underwritten public offering of 3,129,890 shares of common stock. In addition, Anacor announced that the underwriters of this offering exercised their over-allotment option in full and purchased an additional 469,483 shares of common stock. Total gross proceeds ... read more

Immersion Corporation (NASDAQ:IMMR), the leader in developing and licensing touch feedback technology (http://www.immersion.com/corporate/), announced today that Chief Executive Officer Victor Viegas and Chief Financial Officer Paul Norris will present to the investment community at the following investor conferences: ... read more

Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the first quarter ended March 31, 2013. Total revenue for the first quarter of 2013 was $14.5 million, an increase of 33% from $10.9 million in the first quarter of 2012. Product ... read more

Two weeks after the first mailings of powders confirmed to be bioterrorism agents were sent to President Obama, a U.S. Senator, and a Mississippi judge, 20/20 BioResponse reports a substantial increase in orders and inquiries for its patented BioCheck® Suspicious Powder Screening kits. ... read more

Genemarkers is proud to be a sponsor of the Rare Disease Science Challenge: Be HEARD (Helping Empower and Accelerate Research Discoveries) and work with Lori Silveira at National Jewish Health on her research project. Genemarkers will be providing Genomics Expression Analysis for Silveira’s research on Chronic ... read more

Raleigh-based Compass Surgical Partners, a firm that invests in, manages and develops ambulatory surgery centers (ASCs), has acquired an equity interest in a second Tampa-area ASC — Bay Area Physicians Surgery Center in Brandon, Florida. The partnership is effective as ... read more

Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the “Company” or “Medgenics”),, the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announces that all resolutions proposed at the Company’s Annual Meeting of ... read more

Damballa, the experts in advanced threat protection, have promoted Dr. Manos Antonakakis to the role of Chief Scientist. In this role, Antonakakis will direct advanced research and university collaborations for the company. The techniques and technologies developed by the advanced ... read more

Fluidigm (www.fluidigm.com) today announced an agreement to develop and supply a customized version of its high-throughput library prep system to the DKMS (Deutsche Knochenmarkspenderdatei gemeinnützige Gesellschaft mbH) Life Science Lab. The new system will help the DKMS accelerate its research to fight ... read more

The Cisco Connected Energy Networks business unit is working with the Resnick Sustainability Institute at Caltech on important research toward a clean distributed energy future. Cisco’s long history in distributed networks is combined with Resnick’s deep expertise in complex scientific problem-solving. Together, they are discussing ways ... read more

... read more

Lucigen Corporation and Research Corporation Technologies (RCT) today announced a partnership to commercialize and distribute the CleanColi™ Expression System, the first Escherichia coli (E. coli)-based recombinant system that lacks unwanted endotoxin. Lucigen will produce and sell kits containing CleanColi™ competent cells and ... read more

Rebecca Richards-Kortum and Maria Oden established the Beyond Traditional Borders (BTB) engineering design initiative at Rice University in 2006 with the goals of developing and improving access to health innovations for the world’s poorest communities. The professors of bioengineering have guided more than 3,000 students through ... read more